Verity Solutions - Your Experts in 340B Program Compliance
Verity Solutions is a leading provider of 340B software and services. We are driven to help healthcare organizations save money so they can extend care to those who need it most. We partner with customers over the long-term to support on-going compliance and audit readiness.
Read More
Summer 2017 Edition | Health System - Infusion
Verity Solutions - We're Your Experts in 340B Program Compliance
Verity Solutions is a leading provider of 340B software and services. We are driven to help healthcare organizations save money so they can extend care to those who need it most. We partner with customers over the long-term to support on-going compliance and audit readiness.
Read More
Winter 2016 Edition | Health System - Infusion
Verity Solutions - We're Your Experts in 340B Program Compliance
Verity Solutions products simplify the complex process of maintaining 100% 340B program compliance and results in critical cost savings. Our services have saved our customers more than a billion dollars in drug purchases - all while maintaining an impeccable HRSA-compliant audit record.
Read More
Summer 2016 Edition | Health System - Infusion
Talyst Delivers Medication Management and Complete Inventory Control Solutions
AutoPharm Enterprise software by Talyst provides enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety.
Read More
Winter 2015 Edition | Health System - Infusion
Optimize Your 340B Savings While Maintaining HRSA Audit Compliance with Talyst's AutoSplit Software Solutions
Talyst understands a pharmacy's need to optimize its 340B savings. For more than a decade, Talyst has supported over 400 health systems with their AutoSplit 340B software.
Read More
Summer 2015 Edition | Health System - Infusion
AutoSplit Contract Pharmacy and 340B Compliance Services by Talyst
Talyst understands a pharmacy's need to optimize its 340B savings. For more than a decade, Talyst has supported over 400 health systems with their AutoSplit 340B software.
Read More
Winter 2014 Edition | Health System - Infusion
Talyst's 340B Contract & Specialty Pharmacy Solutions
Talyst understands a pharmacy's need to optimize its 340B savings. For more than a decade, Talyst has supported over 400 health systems with their AutoSplit 340B software.
Read More
Summer 2014 Edition | Health System - Infusion
Talyst's 340B Contract & Specialty Pharmacy Solutions
Talyst understands a pharmacy's need to optimize its 340B savings. For almost 10 years, Talyst has supported over 400 health systems with their AutoSplit 340B software.
Read More
Winter 2013 Edition | Health System - Infusion
Talyst's Expert 340B Solutions
Talyst understands a pharmacy's need to optimize its 340B savings. For almost 10 years, Talyst has supported over 400 health systems with their AutoSplit 340B software.
Read More
Summer 2013 Edition | Health System - Infusion
R&S Northeast
R&S focuses on your pharmaceutical and medical supply needs so that you can focus on patient care.
Read More
ScriptPro
ScriptPro's automated, super-intelligent 340B engine qualifies and processes prescription data to give you the confidence to tackle this complexity.
Read More
Verity Solutions
Talyst 340B is now Verity Solutions - We're your experts in 340B program compliance
Read More
Comprehensive Pharmacy Services
Conquering 340B is your mission. We have your secret weapon
Read More
PharmD on Demand
Trusted Pharmacy Solutions. Remote Pharmacy Services, DOP Leadership Positions, 340b Support
Read More
Talyst
Talyst is the leader in 340B splitting software. We understand a pharmacy's need to optimize the value of the 340B program to improve patient care. With increasing complexity and the need for audit compliance, it's critical to have the right solution. Talyst offers a variety of 340B expert solutions: AutoSplit ® 340B Software, AutoSplit ® Fully Managed, AutoSplit ®Contract Pharmacy, and 340B Complaince Services. For over 10 years, Talyst has supported hundreds of health systems with their AutoSplit 340
Read More
Talyst
A successful 340B program has two goals: maximizing savings and maintaining HRSA compliance. Over the past decade, Talyst customers have saved more than a billion dollars in drug purchases utilizing our software and services, all while remaining compliant with ever-changing HRSA regulations.
Read More
Apexus
The 340B Prime Vendor Program is managed by Apexus through a competitively bid contract awarded by HRSA's Office of Pharmacy Affairs, part of the federal government responsible for administering the 340B Drug Pricing Program. As the government's only awarded 340B Prime Vendor, Apexus is responsible for securing sub-ceiling discounts on outpatient drug purchases and discounts on other pharmacy related products and services for participating public hospitals...
Read More
340B Resources & 340B Vendors
What is the 340B Drug Pricing Discount Program?
The 340B Drug Pricing Discount Program is a program developed by Congress, which requires drug manufacturers to sell outpatient drugs at a discount to safety-net providers, also referred to as qualified covered entities, serving high numbers of low-income Medicare, Medicaid and Supplemental Security Insurance patients. The discount is approximately nineteen percent lower than the Medicaid net price. Congress created this program to allow these providers to âstretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.â Savings from 340B help to fund free and low-cost medications, as well as, HIV/AIDS, diabetes, cancer, dental and primary care clinics that serve our most vulnerable citizens. (340B Health)
How does 340B affect patients?
The 340B Drug Pricing Discount Program provides indigent patient populations with access to high-priced medications that would otherwise be inaccessible. The savings resulting from the 340B Program are then used to fund free and low-cost medications, as well as, clinics for HIV/AIDs, diabetes, cancer, dental and primary care for citizens without access to adequate care. This program increases the accessibility of healthcare services and assists in closing the gap in healthcare delivery.
What did the legislation in 2010, as part of the Affordable Care Act, do to the 340B Program?
The change in legislation to 340B, with the introduction of the Affordable Care Act, lowered the restrictions to qualify as a covered entity and expanded the number of covered entities that qualify for the program. Covered entities include: disproportionate share hospitals, childrenâs hospitals, cancer hospitals exempt from Medicare prospective payment system, sole community hospitals, rural centers, and critical access hospitals. To be eligible, these hospitals must be state-contracted, non-profit centers granted power by the government or a private non-profit with a state contract to provide indigent care. All covered entities must meet the Medicaid payer-mix.
What is the 340B Prime Vendor Program?
The 340B Prime Vendor Program (PVP) is managed by Apexus through a contract awarded by Health Resources and Services Administration (HRSA). HRSA is the federal government branch responsible for administering the 340B Drug Pricing Discount Program. HRSA's Office of Pharmacy Affairs (OPA) manages it. As the primary contractor of 340B, Apexus is responsible for negotiating pharmaceutical drug pricing for covered entities, as well as, improving access to affordable medications by establishing a distribution network of pharmaceuticals for covered entities.
The 340B Prime Vendor Program (PVP) is managed by Apexus through a contract awarded by Health Resources and Services Administration (HRSA), the federal government branch responsible for administering the 340B Drug Pricing Program. HRSA's Office of Pharmacy Affairs (OPA) manages the 340B Drug Pricing Program. As the contractor to the 340B Prime Vendor, Apexus is responsible for the negotiation of pharmaceutical pricing below the 340B price as well as improving access to affordable medications by establishing a distribution network for pharmaceuticals to covered entities. We are continually working to add distributors to the Prime Vendor Network and negotiate a portfolio of drugs below the 340B ceiling pricing so that the health care organizations participating in the 340B Prime Vendor program will recognize additional savings and value.
